Skip to main content

Children's Hospital Boston to Use Protein Forest Separation System for Biomarker Discovery

NEW YORK (GenomeWeb News) – Lexington, Mass.-based Protein Forest has installed its digital ProteomeChip System at the Children’s Hospital Boston, the company said recently.

The protein separation system fractionates and concentrates proteins or peptides for mass spectrometry analysis using parallel isoelectric focusing. Along with related MSRAT software, the ProteomeChip will reportedly be used in a National Institutes of Health funded study on chronic pelvic pain led by researchers affiliated with Children’s Hospital Boston and Harvard Medical School.

One of the researchers, Keith Solomon, a Harvard Medical School orthopedic surgery researcher and administrative director of the Children’s Hospital Boston’s Proteomics Center, has been evaluating technologies for discovering new biomarkers in urine. Solomon said in a statement that the research team expects the ProteomeChip and MSRAT software to decrease the amount of time required to identify potential biomarkers.

Financial terms of the agreement were not disclosed.

Last month, Protein Forest announced that is had shipped its ProteomeChip separation system to Thermo Fisher Scientific’s proteomics group.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.